Cyclin-dependent kinase inhibitor 3 (CDKN3), also known as kinase-associated phosphatase (KAP), dephosphorylates activating cyclin-dependent kinase 2 (CDK2) Thr160, yet high expression is associated with aggressive features in some cancers. This review distinguishes messenger RNA (mRNA) expression, protein abundance, p...
Yi Li, Long Cheng, Xiao-Wei Zhang et al.· Frontiers in Oncology· 0 citations